Tin tức & Cập nhật
Xem bài viết Nội tiết
Xem
Chỉ hiển thị Multimedia

Does hormone therapy affect IBD outcomes in transgender, nonbinary patients?
15 Jan 2025
bởiStephen Padilla
Disease activity, as measured by C-reactive protein (CRP), foecal calprotectin (FC), and endoscopic evaluation, does not significantly vary a year following the initiation of gender-affirming hormone (GAH) therapy in transgender and gender nonconforming patients with inflammatory bowel disease (IBD), as shown in a study presented at AIBD 2024.
Does hormone therapy affect IBD outcomes in transgender, nonbinary patients?
15 Jan 2025
NT-proBNP predicts cardiorenal complications in Chinese patients with T2D
30 Dec 2024
bởiChristina Lau
Elevated N-terminal pro–B-type natriuretic peptide (NT-proBNP) levels independently predict cardiorenal complications in Chinese patients with type 2 diabetes (T2D) and can be utilized as a clinical prognostic biomarker for risk stratification to enable more intensive organ-protective treatment in those at risk, a study involving 1,993 patients enrolled in the Hong Kong Diabetes Biobank has shown.







